The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • e-Health company G Medical Innovations (GMV) continues its rapid growth in the U.S., particularly after its uptake of remote patient services
  • Between January and October 2019, the company added nearly 24,000 patients to its remote services
  • These services aim to improve access to medical data and care for people living remotely
  • G Medical expects the growth will continue stemming from the provision of remote monitoring independent diagnostic testing facility (IDTF) services to a major hospital chain in Ohio
  • Additionally, the go-getter is pursuing new contracts across the country to implement and extend its services
  • Shares have soared 33.3 per cent today and are trading for 12 cents each

e-Health company G Medical Innovations (GMV) has updated the market on its rapid growth across the U.S. during the 2019 calendar year.

Founded in 2014, G Medical specialises in innovative mobile and e-Health solutions. It uses its suite of software devices, as well as patient service operations, to drive revenue.

Amongst its operations is its remote patient services whereby G Medical improves remote access to medical data and quality of care, and has done since 2018.

Since the launch of this service, this calendar year has seen a considerable uptake of remote patient services.

Between January and October this year, G Medical has deployed service access to nearly 24,000 patients. This represents an approximate 105 per cent increase since the previous year.

“The company is witnessing tremendous momentum build across the US, which is a key market for GMV. We look forward to continuing this growth well across 2020 and unlocking the considerable revenue that will accompany uptake,” CEO and Executive Director Dr Yacov Geva said.

G Medical expects the growth will continue next year following the potential provision of remote monitoring independent diagnostic testing facility (IDTF) services to an existing client.

The company plans to introduce its IDTF services to the client who is a major hospital chain in Ohio which may add 5000 patients per year.

Additionally, the go-getter is pursuing new contracts across the country to implement and extend its services.

Discreetly, the company noted it was taking part in advanced discussions with a large payer organisation in Texas and further updates will be given soon.

To support additional growth, G medical is in the final stages of hiring four sales representatives. These appointments will allow the company to progress new market entries in the U.S. and further underpins its rapid expansion.

Shares have soared 33.3 per cent today and are trading for 12 cents each at 3:57 pm AEDT.

GMV by the numbers
More From The Market Online

Inoviq closes the gap on blood test results for ovarian cancer

INOVIQ has announced encouraging blood test identification results for ovarian cancer – cancer-positive tests saw a…

Paradigm Biopharma on track to US Phase III osteo program

Paradigm Biopharma has announced its completion of a submission to the US FDA to progress to…

Firebrick Pharma’s US launch of Nasal Spray is nothing to be sneezed at

Australian pharmaceutical developer, Firebrick Pharma (ASX:FRE) has launched its latest product, Nasodine Nasal Spray, in the…